Fylde and Wyre Policies

Click each header to expand its content

Commissioning Policies

Application Amendment Waiver of Policies for the Comm of Appropriate Effective and Priority Health Care 0.4 MB75
Commissioning Policies Introduction Document 89 KB99
Considering Applications For Exceptionality 0.3 MB147
General Policy IFR Decision Making 0.4 MB100
Policy for Assisted Conception Services 0.3 MB173
Policy for Benign Skin Lesion (updated September 2019) 0.2 MB57
Policy for Breast Reduction (updated September 2019) 0.2 MB40
Policy for Carpal Tunnel Syndrome updated October 2019 0.2 MB40
Policy for Chalazia Removal 0.2 MB71
Policy for Choice of Service Provide 0.2 MB97
Policy For Commissioning Spinal Injection Radiofrequency Denervation For Low Back Pain 0.6 MB89
Policy for Commissioning Spinal Injections and Radiofrequency Denervation for Low Back Pain 0.4 MB114
Policy for Complementary and Alternative Therapies 88 KB84
Policy for Complex Cases 0.2 MB76
Policy for Cosmetic Procedures (updated September 2019) 0.2 MB53
Policy for Dilatation and Curettage 45 KB61
Policy for Dupuytren's contracture 0.3 MB79
Policy for Endoscopic Procedures on the Knee Joint Cavity 0.2 MB75
Policy for excision of the uterus 0.1 MB74
Policy for ganglia excision 0.2 MB59
Policy for Glucose Monitoring Devices (March 19 amends) 0.3 MB168
Policy for Grommets (updated September 2019) 0.2 MB17
Policy for Gynaecomastia (updated September 2019) 0.2 MB21
Policy for Haemorrhoid surgery 0.2 MB57
Policy for Hip Arthroscopy 42 KB90
Policy for hysteroscopy 44 KB62
Policy for hysteroscopy 0.1 MB33
Policy for insulin pump provision 0.1 MB66
Policy for Lumbar spine procedures 0.3 MB64
Policy for Male Circumcision 0.2 MB102
Policy for Monitoring and Enforcing CCG Policies 0.1 MB80
Policy for photorefractive surgery 0.1 MB69
Policy for Reversal of Sterilisation 0.1 MB89
Policy for Reversal of Sterilisation 0.1 MB34
Policy for services that are the subject of guidance from NICE 0.1 MB107
Policy for snoring surgery 0.2 MB60
Policy for Specified Expensive Services 0.1 MB74
Policy for Specified Non-clinical issues 0.1 MB74
Policy for Specified Services for which provision in service agreements may be limited 0.2 MB95
Policy for Surgical Release of Trigger Finger (updated September 2019) 0.2 MB23
Policy for testing for Malignant Hyperthermia 0.1 MB95
Policy for Tonsillectomy (updated September 2019) 0.2 MB46
Policy for varicose veins 0.2 MB24
Policy Process map appeals 0.1 MB75
Policy Spinal Cord Stimulation 38 KB106
Policy subacromial decompression 0.2 MB55
Statement Of Principles 0.3 MB74

Commissioning Policy summaries

Corporate Policies

Information Governance

Medicines Optimisation

Actipatch for pain management 0.6 MB168
Albiglutide for type-2 diabetes mellitus 0.3 MB108
Alprostadil Cream For ED 0.3 MB84
Azelastine Fluticasone (Dymista) Nasal Spray 0.1 MB130
Bazedoxifene for oestrogen deficiency symptoms 0.3 MB98
Botulinum Toxin A for Spasticity and Contracture of the joint 0.3 MB98
Brimonidine For Erythema Of Rosacea 0.1 MB88
Brivaracetam for epilepsy 0.3 MB94
Budesonide multimatrix MMX 9mg prolonged release tablets 0.2 MB119
Certolizumab For Psoriatic Arthritis 0.1 MB75
Co-Proxamol For pain management 0.3 MB197
Co-trimoxazole for the prophylaxis of pneumocystis jirovecii (pneumocystis carinii) infections 0.3 MB94
Co-trimoxazole Prophylaxis of Primary and Secondary Spontaneous Bacterial Peritonitis (SBP) 0.1 MB94
Colesevelam (Cholestagel® ) For combination or monotherapy for familial hypercholesterolaemia 0.3 MB93
Colistimethate sodium/Colistin sulfomethate sodium (Colomycin® ) For non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa 0.2 MB65
Conditions for which over the counter items should not routinely be prescribed in primary care 0.9 MB198
Daily selective serotonin re-uptake inhibitors (SSRIs) for the treatment of premature ejaculation (PE) 0.2 MB67
Dapoxetine for the treatment of premature ejaculation (PE) 0.2 MB72
Denosumab for GIO 0.2 MB49
Dulaglutide for the treatment of Type II Diabetes Mellitus in adults 0.3 MB101
Eflornithine-cream-for-facial-hirsutism 0.2 MB94
Eltrombopag For Thrombocytopenia In Hepatitis C 0.1 MB59
Eslicarbazepine For Focal Seizures 0.1 MB82
Evolocumab (Repatha SureClick® ) For prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin 0.1 MB94
Ferric Maltol 30mg Capsules in Adults for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease 0.3 MB95
Fluorouracil-5-cream-for-basal-cell-carcinomas 0.1 MB53
Gluten-Free-Food-Products 0.3 MB93
Guanfacine-for-ADHD 0.3 MB84
Imiquimod-5-cream-for-basal-cell-carcinomas 0.2 MB79
Insulin Degludec And Liraglutide 0.2 MB70
Insulin-Aspart-for-Diabetes-Mellitus 0.3 MB88
Insulin-Degludec-for-DM 0.3 MB89
Insulin-Detemir-for-DM 0.2 MB63
Insuline-Glargine-for-T1DM 0.3 MB71
Insuline-Glargine-for-T2DM 0.3 MB74
Invicorp-injection-for-erectile-dysfunction 0.3 MB102
Ivermectin-cream-for-rosacea 0.3 MB87
JIA Policy For Adults (Version 1.0) 0.2 MB67
Lamotrigine-for-trigeminal-neuralgia 0.3 MB81
Lamotrigine-for-trigeminal-neuralgia 2 0.3 MB102
Levonorgestrel 13.5mg IUD 0.3 MB63
Lidocaine Plasters For PHN 0.2 MB72
Lidocaine-plasters-for-unlicensed-indications 0.3 MB136
Liothyronine-for-refractory-hypothyroidism 0.2 MB105
Liraglutide-for-obesity 0.3 MB87
Lisdexamfetamine-for-ADHD-in-adults 0.3 MB88
Lisdexamfetamine-for-ADHD-update 0.3 MB80
Lurasidone-for-Schizophrenia 0.3 MB96
Magnaspartate For Hypomagnesaemia 0.3 MB120
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 0.2 MB75
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 2 0.2 MB56
Midazolam-Epistatus-for-seizures 0.2 MB96
Opicapone-for-Parkinsons-disease-v2 0.5 MB104
Ospemifene for VVA 0.2 MB88
Oxycodone-Naloxone-for-Restless-legs 0.3 MB73
Paravit-CF-for-dietary-management-of-patients-with-cystic-fibrosis 0.2 MB240
Patiromer-for-hyperkalaemia 0.3 MB71
Patiromer-for-hyperkalaemia 2 0.3 MB89
Phosphodiesterase Type-5 Inhibitors 0.2 MB63
Pitolisant-for-Narcolepsyv2 0.3 MB72
Policy On Brand Inhaler Prescribing 0.3 MB92
Probiotics And VSL 0.3 MB81
Relvar Ellipta for COPD and asthma in adults 63 KB64
Rituximab-for-AIHA 0.4 MB92
Rituximab-for-ITP 0.4 MB80
Rivaroxaban-10mg-for-DVT-and-PE-and-extended-use 0.1 MB87
Safinamide-for-Parkinsons-disease 0.3 MB98
Second Line Anti-TNF For PsA 0.2 MB84
Second-generation-LA-antipsychotics 0.3 MB97
Secukinumab-for-Palmoplantar-psoriasis 0.3 MB66
Secukinumab-for-Palmoplantar-psoriasis 2 0.3 MB78
Semaglutide for type 2 DM 0.2 MB49
Silk Garments For Eczema And Dermatitis 0.2 MB66
Simbrinza for chronic open angle glaucoma 0.1 MB62
Sodium Oxybate for Narcolepsy with Cataplexy 0.3 MB85
Spironolactone For Acne 0.1 MB85
Subcutaneous Depot Medroxyprogesterone Acetate 0.1 MB78
Tadalafil daily 0.3 MB99
Tapentadol for neuropathic pain in non-palliative care 0.4 MB94
Tapentadol for non-specific pain 0.2 MB79
Testosterone For Female Sexual Dysfunction 0.1 MB57
Tiotropium For Asthma 0.2 MB59
Tocilizumab SC For RA 0.1 MB60
Trelegy inhaler for COPD 0.3 MB87
Trimbow inhaler for COPD 0.4 MB99
Trimbow-inhaler-for-COPD 0.4 MB6
Ulipristal acetate for uterine fibroids 0.5 MB82
Umeclidinium For COPD 0.2 MB59
Vedolizumab For Crohn's Disease 0.2 MB51
Vesomni For Benign Prostatic Hyperplasia 0.1 MB65
Vitamins (inc Renavit) For Dialysis 0.3 MB92
Waterproof Cast Cover Policy 0.1 MB122
Xonvea for nausea and vomiting in pregnancy 0.1 MB53

Last updated on 17 September 2019 at 15:48 by communications manager